Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age
journal contribution
posted on 2024-07-26, 01:21authored byDesmond Curran, Eugene AthanEugene Athan, Javier Diez-Domingo, Wayne Ghesquiere, Thomas C Heineman, Himal Lal, Edward Leung, Myron J Levin, Sean Matthews, Janet E McElhaney, Shelly A McNeil, Lidia Oostvogels, Karlis Pauksens, Joan Puig-Barbérà, Antonio Volpi, Daisuke Watanabe, Wilfred Yeo, Robert W Johnson
Quality-of-Life Impact of an Investigational Subunit-Adjuvanted Herpes Zoster Vaccine in Adults ≥50 Years of Age